Comparative Effectiveness of Lenalidomide/Dexamethasone-Based Triplet Regimens for Treatment of Relapsed and/or Refractory Multiple Myeloma in Subgroups Defined By Cytogenetic Risk

Blood(2022)

引用 0|浏览7
暂无评分
关键词
multiple myeloma,refractory multiple myeloma,lenalidomide/dexamethasone-based,cytogenetic risk
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要